EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and Internal Validation of a Competing‐Risk Nomogram for Predicting Cancer‐Specific Death in Oral Cavity Squamous Cell Carcinoma

Kuan-Yu Chu iD

Oral Diseases · 01.11.2026

DOI: 10.1111/odi.70556 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, online erschienen am 01.11.2026. Verfasst von Kuan-Yu Chu. Beteiligte Einrichtung: School of Dentistry and Graduate Institute of Dental Science, College of Oral Medicine, National Defense Medical University, Taipei, Taiwan. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Oral cavity squamous cell carcinoma (OCSCC) patients face competing risks of cancer and non‐cancer death. This study developed and internally validated a competing‐risk nomogram for cancer‐specific death.

Methods

A total of 84,456 SEER 17‐registry adults (age ≥ 20 years) with OCSCC (2000–2023) were identified. A Fine–Gray model was fit on a 70% training split, with backward elimination of nine candidate predictors (gender retained a priori). The nomogram, predicting 3‐ and 5‐year cancer‐specific death, was evaluated on the 30% test set against a stage‐only benchmark, with Cox sensitivity analyses.

Results

The final model retained age, race, subsite, grade, stage, surgery, radiation and gender. Distant (vs. localized) stage (sHR 3.48, 95% CI: 3.30–3.66) and surgery (sHR 0.48, 95% CI: 0.46–0.50) were the strongest predictors. Time‐dependent AUC was 0.777 (3‐year) and 0.765 (5‐year), 5–6 points above the stage‐only model ( p < 0.001), with good calibration and Brier scores better than a null model ( p < 0.001). Proportional‐hazards assumptions were violated ( p < 0.001), so estimates are time‐averaged; radiation's estimated direction differed between Fine–Gray and Cox models, likely reflecting confounding by indication.

Conclusion

This competing‐risk nomogram provides individualized, reasonably well‐calibrated 3‐ and 5‐year cancer‐specific death risk estimates for OCSCC. External validation is needed before clinical use.

Schlagwörter

Stichwörter der Autor:innen

Fine–Gray modelSEER programcumulative incidencemouth neoplasmsproportional hazards modelsrisk assessment

Autor:innen und Institutionen

  • School of Dentistry and Graduate Institute of Dental Science, College of Oral Medicine, National Defense Medical University, Taipei, Taiwan.
  • Department of Health and Welfare, University of Taipei, Taipei, Taiwan.

ORCID-Profile: Kuan-Yu Chu

Zitieren

APA

Chu, K. Y. (2026). Development and Internal Validation of a Competing‐Risk Nomogram for Predicting Cancer‐Specific Death in Oral Cavity Squamous Cell Carcinoma. Oral Diseases. https://doi.org/10.1111/odi.70556

Vancouver

Chu KY. Development and Internal Validation of a Competing‐Risk Nomogram for Predicting Cancer‐Specific Death in Oral Cavity Squamous Cell Carcinoma. Oral Diseases. 2026. doi:10.1111/odi.70556

BibTeX
@article{Chu2026,
  author = {Chu, Kuan-Yu},
  title = {Development and Internal Validation of a Competing‐Risk Nomogram for Predicting Cancer‐Specific Death in Oral Cavity Squamous Cell Carcinoma},
  journal = {Oral Diseases},
  year = {2026},
  doi = {10.1111/odi.70556}
}
Kostenlos starten →